A Review of the Common Neurodegenerative Disorders: Current Therapeutic Approaches and the Potential Role of Bioactive Peptides DOI
Kuldeep Singh, Jeetendra Kumar Gupta, Shivendra Kumar

и другие.

Current Protein and Peptide Science, Год журнала: 2024, Номер 25(7), С. 507 - 526

Опубликована: Апрель 2, 2024

Abstract:: Neurodegenerative disorders, which include Alzheimer's disease (AD), Parkinson's (PD), Huntington's (HD), and amyotrophic lateral sclerosis (ALS), represent a significant growing global health challenge. Current therapies predominantly focus on symptom management rather than altering progression. In this review, we discuss the major therapeutic strategies in practice for these highlighting their limitations. For AD, mainstay treatments are cholinesterase inhibitors N-methyl-D-aspartate (NMDA) receptor antagonists. PD, dopamine replacement therapies, including levodopa, commonly used. HD is managed primarily with symptomatic treatments, reusable extends survival ALS. However, none of halts or substantially slows neurodegenerative process. contrast, review highlights emerging research into bioactive peptides as potential agents. These naturally occurring synthetically designed molecules can interact specific cellular targets, potentially modulating processes. Preclinical studies suggest that may mitigate oxidative stress, inflammation, protein misfolding, common pathological features diseases. Clinical trials using neurodegeneration limited but show promising initial results. instance, hemiacetal, γ-secretase inhibitor peptide, has shown AD by reducing amyloid-beta production, though its development was discontinued due to side effects. Despite advancements, many challenges remain, identifying optimal peptides, confirming mechanisms action, overcoming obstacles related delivery brain. Future should prioritize discovery novel improve our understanding pharmacokinetics pharmacodynamics. Ultimately, approach lead more effective moving beyond modify course devastating

Язык: Английский

Nanocarriers based novel and effective drug delivery system DOI Creative Commons
Sumera Khizar,

Noor Alrushaid,

Firdos Alam Khan

и другие.

International Journal of Pharmaceutics, Год журнала: 2022, Номер 632, С. 122570 - 122570

Опубликована: Дек. 29, 2022

Язык: Английский

Процитировано

93

Biogenesis, Isolation, and Detection of Exosomes and Their Potential in Therapeutics and Diagnostics DOI Creative Commons
Smrity Sonbhadra,

Mehak Mehak,

Lalit M. Pandey

и другие.

Biosensors, Год журнала: 2023, Номер 13(8), С. 802 - 802

Опубликована: Авг. 10, 2023

The increasing research and rapid developments in the field of exosomes provide insights into their role significance human health. Exosomes derived from various sources, such as mesenchymal stem cells, cardiac tumor to name a few, can be potential therapeutic agents for treatment diseases could also serve biomarkers early detection diseases. Cellular components exosomes, several proteins, lipids, miRNAs hold promise novel structure enables them drug delivery vehicles. Since exhibit applications, efficient isolation complex biological/clinical samples precise real-time analysis becomes significant. With advent microfluidics, nano-biosensors are being designed capture efficiently rapidly. Herein, we have summarized history, biogenesis, characteristics, functions, applications along with isolation, detection, quantification techniques. implications surface modifications enhance specificity been outlined. review sheds light on engineered nanoplatforms developed exosome capture.

Язык: Английский

Процитировано

43

Extracellular Vesicles and Exosomes: Novel Insights and Perspectives on Lung Cancer from Early Detection to Targeted Treatment DOI Creative Commons
S. Rahimian, Hossein Najafi, Baran Afzali

и другие.

Biomedicines, Год журнала: 2024, Номер 12(1), С. 123 - 123

Опубликована: Янв. 7, 2024

Lung cancer demands innovative approaches for early detection and targeted treatment. In addressing this urgent need, exosomes play a pivotal role in revolutionizing both the treatment of lung cancer. Their remarkable capacity to encapsulate diverse range biomolecules, traverse biological barriers, be engineered with specific targeting molecules makes them highly promising diagnostic markers precise drug delivery cells. Furthermore, an in-depth analysis exosomal content biogenesis offers crucial insights into molecular profile tumors. This knowledge holds significant potential development therapies strategies Despite notable progress field, challenges standardization cargo loading persist. Collaborative research efforts are imperative maximize advance field precision medicine benefit patients.

Язык: Английский

Процитировано

25

Exosome derived from tumor-associated macrophages: biogenesis, functions, and therapeutic implications in human cancers DOI Creative Commons

Manli Zhou,

Xiaoyun He, Cheng Mei

и другие.

Biomarker Research, Год журнала: 2023, Номер 11(1)

Опубликована: Ноя. 19, 2023

Abstract Tumor-associated macrophages (TAMs), one of the most abundant immune cell types in tumor microenvironment (TME), account for approximately 50% local hematopoietic cells. TAMs play an important role tumorigenesis and development through crosstalk between various cells cytokines TME. Exosomes are small extracellular vesicles with a diameter 50–150 nm, that can transfer biological information (e.g., proteins, nucleic acids, lipids) from secretory to recipient circulatory system, thereby influencing progression human diseases, including cancer. Recent studies have suggested TAMs-derived exosomes crucial roles malignant proliferation, invasion, metastasis, angiogenesis, responses, drug resistance, metabolic reprogramming. potential be targeted therapy. In addition, abnormal expression non-coding RNAs proteins is closely related clinicopathological features patients cancer, these expected become new liquid biopsy markers early diagnosis, prognosis, monitoring tumors. this review, we explored provide diagnostic biomarkers therapeutic targets cancer prevention.

Язык: Английский

Процитировано

33

Exosomes in brain diseases: Pathogenesis and therapeutic targets DOI Creative Commons
Qingying Si, Linlin Wu,

Deshui Pang

и другие.

MedComm, Год журнала: 2023, Номер 4(3)

Опубликована: Июнь 1, 2023

Exosomes are extracellular vesicles with diameters of about 100 nm that naturally secreted by cells into body fluids. They derived from endosomes and wrapped in lipid membranes. involved intracellular metabolism intercellular communication. contain nucleic acids, proteins, lipids, metabolites the cell microenvironment cytoplasm. The contents exosomes can reflect their cells' origin allow observation tissue changes states under disease conditions. Naturally have specific biomolecules act as "fingerprint" parent cells, changed pathological conditions be used biomarkers for diagnosis. low immunogenicity, small size, cross blood-brain barrier. These characteristics make unique engineering carriers. incorporate therapeutic drugs achieve targeted drug delivery. carriers therapy still infancy, but exosome provides a new perspective cell-free therapy. This review discussed relationship occurrence treatment some neuropsychiatric diseases. In addition, future applications diagnosis disorders were evaluated this review.

Язык: Английский

Процитировано

31

Exosomes in liver fibrosis: The role of modulating hepatic stellate cells and immune cells, and prospects for clinical applications DOI Creative Commons
Yufei Liu,

Yuhong Zheng,

Yang Yang

и другие.

Frontiers in Immunology, Год журнала: 2023, Номер 14

Опубликована: Март 20, 2023

Liver fibrosis is a global health problem caused by chronic liver injury resulting from various factors. Hepatic stellate cells (HSCs) have been found to play major role in fibrosis, and pathological stimuli lead their transdifferentiation into myofibroblasts. Complex multidirectional interactions between HSCs, immune cells, cytokines are also critical for the progression of fibrosis. Despite advances treatments they do not meet current medical needs. Exosomes extracellular vesicles 30-150 nm diameter capable intercellular transport molecules such as lipids, proteins nucleic acids. As an essential mediator communication, exosomes involved physiological processes many diseases. In pathogenesis mainly regulating activation HSCs interaction cells. Serum-derived promising biomarkers therapeutic potential derived mesenchymal stem other exhibit anti-liver effects. Moreover, may serve targets hold promise becoming drug carriers treatment.

Язык: Английский

Процитировано

26

Engineered exosome-mediated messenger RNA and single-chain variable fragment delivery for human chimeric antigen receptor T-cell engineering DOI
Ke Si, Zhu Dai, Zhanping Li

и другие.

Cytotherapy, Год журнала: 2023, Номер 25(6), С. 615 - 624

Опубликована: Фев. 23, 2023

Язык: Английский

Процитировано

23

Exosome-like systems: Nanotechnology to overcome challenges for targeted cancer therapies DOI
Jenifer García-Fernández, María de la Fuente

Cancer Letters, Год журнала: 2023, Номер 561, С. 216151 - 216151

Опубликована: Март 29, 2023

Язык: Английский

Процитировано

22

Exosome: From biology to drug delivery DOI

Himakshi Baruah,

Anupam Sarma,

Debojeet Basak

и другие.

Drug Delivery and Translational Research, Год журнала: 2024, Номер 14(6), С. 1480 - 1516

Опубликована: Янв. 22, 2024

Язык: Английский

Процитировано

14

Insight into the Functional Dynamics and Challenges of Exosomes in Pharmaceutical Innovation and Precision Medicine DOI Creative Commons
Anu Sharma, Anita Yadav,

Aparajita Nandy

и другие.

Pharmaceutics, Год журнала: 2024, Номер 16(6), С. 709 - 709

Опубликована: Май 24, 2024

Of all the numerous nanosized extracellular vesicles released by a cell, endosomal-originated exosomes are increasingly recognized as potential therapeutics, owing to their inherent stability, low immunogenicity, and targeted delivery capabilities. This review critically evaluates transformative of exosome-based modalities across pharmaceutical precision medicine landscapes. Because precise biomolecular cargo delivery, posited ideal candidates in drug enhancing regenerative strategies, advancing diagnostic technologies. Despite significant market growth projections exosome therapy, its utilization is encumbered substantial scientific regulatory challenges. These include lack universally accepted protocols for isolation complexities associated with navigating environment, particularly guidelines set forth U.S. Food Drug Administration (FDA). presents comprehensive overview current research trajectories aimed at addressing these impediments discusses prospective advancements that could substantiate clinical translation exosomal therapies. By providing analysis both capabilities hurdles therapeutic applications, this article aims inform direct future paradigms, thereby fostering integration systems into mainstream practice.

Язык: Английский

Процитировано

14